Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-13 @ 12:58 PM
Study NCT ID:
NCT04743804
Status:
TERMINATED
Last Update Posted:
2024-10-01
First Post:
2021-01-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALXN1210-TMA-315
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None